NL7415602A - Werkwijze voor het bereiden van peptiden. - Google Patents

Werkwijze voor het bereiden van peptiden.

Info

Publication number
NL7415602A
NL7415602A NL7415602A NL7415602A NL7415602A NL 7415602 A NL7415602 A NL 7415602A NL 7415602 A NL7415602 A NL 7415602A NL 7415602 A NL7415602 A NL 7415602A NL 7415602 A NL7415602 A NL 7415602A
Authority
NL
Netherlands
Prior art keywords
preparing peptides
peptides
preparing
Prior art date
Application number
NL7415602A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7415602A publication Critical patent/NL7415602A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
NL7415602A 1973-12-06 1974-11-29 Werkwijze voor het bereiden van peptiden. NL7415602A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2360794A DE2360794C2 (de) 1973-12-06 1973-12-06 Verfahren zur Herstellung von Peptiden

Publications (1)

Publication Number Publication Date
NL7415602A true NL7415602A (nl) 1975-06-10

Family

ID=5900062

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7415602A NL7415602A (nl) 1973-12-06 1974-11-29 Werkwijze voor het bereiden van peptiden.

Country Status (12)

Country Link
US (1) US3960830A (nl)
JP (1) JPS5088003A (nl)
BE (1) BE823064A (nl)
CH (1) CH605679A5 (nl)
DE (1) DE2360794C2 (nl)
DK (1) DK633374A (nl)
FR (1) FR2253736B1 (nl)
GB (1) GB1464938A (nl)
IE (1) IE40281B1 (nl)
LU (1) LU71415A1 (nl)
NL (1) NL7415602A (nl)
SE (1) SE7415305L (nl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH611878A5 (nl) * 1974-07-04 1979-06-29 Takeda Chemical Industries Ltd
DE2930542A1 (de) * 1979-07-27 1981-02-12 Hoechst Ag Neue insulinderivate und verfahren zu ihrer herstellung
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
US4766106A (en) * 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4908404A (en) * 1988-08-22 1990-03-13 Biopolymers, Inc. Synthetic amino acid-and/or peptide-containing graft copolymers
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5565519A (en) * 1988-11-21 1996-10-15 Collagen Corporation Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
JPH0520266U (ja) * 1991-01-31 1993-03-12 松下電器産業株式会社 電気部品の接続装置
EP0536671B1 (de) * 1991-10-07 1996-03-06 Hoechst Aktiengesellschaft Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung
US6458889B1 (en) 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
PT876165E (pt) * 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Composicoes de polimeros reticulados e processos para a sua utilizacao
US7883693B2 (en) 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
DE69936322T2 (de) * 1998-08-28 2008-02-21 Amylin Pharmaceuticals, Inc., San Diego Polyamideketten von genauer Länge und deren Konjugate mit Proteinen
EP1121156B1 (en) * 1998-10-16 2006-02-22 Biogen Idec MA Inc. Polymer conjugates of interferon beta- 1a and their uses
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US8129330B2 (en) * 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
DE60331367D1 (de) * 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
WO2004060405A2 (en) * 2002-12-30 2004-07-22 Angiotech International Ag Tissue reactive compounds and compositions and uses thereof
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
KR101148445B1 (ko) 2004-04-28 2012-07-05 안지오디바이스 인터내셔널 게엠베하 가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및 이와 관련된 제조 및 사용 방법
CA2579790A1 (en) * 2004-07-30 2006-02-09 Mount Sinai School Of Medicine Of New York University Npc1l1 and npc1l1 inhibitors and methods of use thereof
EP1796602A4 (en) 2004-09-17 2016-10-19 Angiotech Pharm Inc MULTIFUNCTIONAL COMPOUNDS FOR PRODUCING NETWORKED BIOMATERIALS AND MANUFACTURING AND USE METHOD THEREFOR
AU2006293180A1 (en) 2005-09-20 2007-03-29 Jitsubo Co., Ltd. Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
SG178780A1 (en) * 2007-02-12 2012-03-29 Biotempt Bv Treatment of trauma-hemorrhage with short oligopeptides
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
JP5647146B2 (ja) 2008-12-29 2014-12-24 トレベナ・インコーポレイテッドＴｒｅｖｅｎａ， Ｉｎｃ． β−アレスチンエフェクターおよび組成物およびその使用方法
US9518086B2 (en) * 2014-02-07 2016-12-13 Trevena, Inc. Crystalline and amorphous forms of a β-arrestin effector
EP3145524A4 (en) 2014-05-19 2018-03-14 Trevena, Inc. Synthesis of beta-arrestin effectors
EP3169406A4 (en) * 2014-07-14 2018-01-10 PEG Biosciences, Inc. Polymeric enkephalin prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (nl) * 1967-05-23 1971-08-02 Pharmacia Ab
US3502545A (en) * 1968-09-27 1970-03-24 Monsanto Co Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel

Also Published As

Publication number Publication date
IE40281B1 (en) 1979-04-25
SE7415305L (nl) 1975-06-09
US3960830A (en) 1976-06-01
CH605679A5 (nl) 1978-10-13
GB1464938A (en) 1977-02-16
DE2360794A1 (de) 1975-06-26
JPS5088003A (nl) 1975-07-15
BE823064A (fr) 1975-06-06
FR2253736A1 (nl) 1975-07-04
IE40281L (en) 1975-06-06
FR2253736B1 (nl) 1978-09-15
LU71415A1 (nl) 1976-11-11
DK633374A (nl) 1975-07-21
DE2360794C2 (de) 1984-12-06

Similar Documents

Publication Publication Date Title
NL7415602A (nl) Werkwijze voor het bereiden van peptiden.
NL7408940A (nl) Werkwijze voor het bereiden van peptiden.
NL7412489A (nl) Werkwijze voor het bereiden van polyether- n.
NL7411871A (nl) Werkwijze voor het bereiden van entcopolymeren.
NL7412946A (nl) Werkwijze voor het bereiden van polyurethan- m.
NL7506035A (nl) Werkwijze voor het bereiden van eiwithydrolysa- ten.
NL7505590A (nl) Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
NL7414946A (nl) Werkwijze voor het bereiden van farmaceutische preparaten.
NL7607987A (nl) Werkwijze voor het bereiden van peptiden.
NL7409806A (nl) Werkwijze voor het bereiden van difenylhydan- toinen.
NL7415820A (nl) Werkwijze voor het bereiden van aminover- bindingen.
NL7413822A (nl) Werkwijze voor het bereiden van imiden.
NL7412944A (nl) Werkwijze voor het epoxyderen van alkenen.
NL7416935A (nl) Werkwijze voor het bereiden van p-nitroben- ur.
NL7415508A (nl) Werkwijze voor het bereiden van amines.
NL7411084A (nl) Werkwijze voor het bereiden van cyclopentenon- derivaten.
NL158166B (nl) Werkwijze voor het bereiden van dimethyltereftalaat.
BE815329A (nl) Werkwijze voor het bereiden van alkenen
NL166925C (nl) Werkwijze voor het bereiden van peptiden.
NL7411278A (nl) Werkwijze voor het bereiden van antimoon- glycoloxyde.
NL170729C (nl) Werkwijze voor het bereiden van 1-aminoantrachinon.
NL183188C (nl) Werkwijze voor het bereiden van cyaanpyridinen.
NL7412762A (nl) Werkwijze voor het bereiden van (alpha)-6-desoxyte- clinen.
NL7416786A (nl) Werkwijze voor het bereiden van gesubstitueerde 2-benzoylpyridinen.
NL166924C (nl) Werkwijze voor het bereiden van peptiden.